Marsh Linda

Marsh Linda is listed in filings as Director at Fulgent Genetics, Inc.. This profile follows SEC Form 4 activity through Nov 5, 2025, including 7 public disclosures. Recent filings connect the profile to Fulgent Genetics, Inc. (FLGT) and Astrana Health, Inc. (ASTH). The current snapshot covers public activity from Aug 14, 2024 to Nov 5, 2025. Reported amounts are shown as $168.8K to $364.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.